Strata critical medical forecasts $285M-$295M 2026 revenue while targeting logistics gross margin back to 20% in 2027 (NASDAQ:SRTA)

Strata Critical Medical (SRTA) Q2 2026 earnings call: raised 2026 guidance, clinical growth, acquisitions, and logistics risks.

Continue in Briflio to read, react, comment, and share.